Holen Sie sich die Stockscreener-App
5.66
3.90%
-0.23
Handel nachbörslich:
5.69
0.03
+0.53%
Schlusskurs vom Vortag:
$5.89
Offen:
$5.8
24-Stunden-Volumen:
183.14K
Relative Volume:
3.21
Marktkapitalisierung:
$813.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
-10.58%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$5.40
$6.0571
1-Wochen-Bereich:
$5.3444
$6.85
52-Wochen-Spanne:
$3.015
$14.29
Ss Innovations International Inc Stock (SSII) Company Profile
Firmenname
Ss Innovations International Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SSII mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SSII
Ss Innovations International Inc
|
5.66 | 813.14M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
136.26 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.78 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.74 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.75 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.18 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Ss Innovations International Inc Aktie (SSII) Neueste Nachrichten
SS Innovations’ robot used in its first cardiac surgery in Americas - MedTech Dive
SS Innovations completes its first cardiac surgery in the Americas with SSi Mantra - The Robot Report
SS Innovations Completes Robotic Cardiac Surgery Using SSi Mantra 3 System - MarketScreener
SS Innovations Completes First Robotic Cardiac Surgery - TipRanks
First robotic cardiac surgery in Americas performed with SSi Mantra - Investing.com
SS Innovations Achieves Milestone with First Robotic Cardiac Surgery in the Americas Using SSi Mantra 3 System - Nasdaq
SS Innovations Announces Successful Completion of First - GlobeNewswire
Medical Milestone: First Robotic Heart Surgery in Americas Succeeds with New SSi Mantra Technology - Stock Titan
Proud moment for the nation, Indian Medtech Start-up rings the bell in New York, Celebrates Nasdaq Debut - Goa Chronicle
Top 3 Health Care Stocks That May Rocket Higher This Quarter - Benzinga
Proud Moment For The Nation, Indian Medtech Start-Up Rings The Bell In New York, Celebrates Nasdaq Debut - businessnewsthisweek.com
SS Innovation Pursues FDA Approval For Surgical Robotic System - RTTNews
Proud Moment for India: SS Innovations Rings Nasdaq Opening Bell, Showcases Indian Medtech Excellence on Global Stage - udaipurkiran.com
Indian medtech start-up SS Innovations makes Nasdaq debut, showcasing global leadership in robotic surgery - eHealth Magazine
Indian medtech startup SSII celebrates debut on Nasdaq - News9live
SS Innovations International rings Nasdaq opening bell, putting Indian medtech on the global map - Healthcare Radius
SS Innovations Unveils New Strategic Expansion Plans - TipRanks
SS Innovations International Inc Rings the Opening Bell - Nasdaq
SS Innovations Rings Nasdaq Bell After Uplisting - TipRanks
SS Innovations International, Inc. to Ring Nasdaq Opening Bell Celebrating Uplisting and Milestone Surgeries - Nasdaq
SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025 - GlobeNewswire
SS Innovations reaches 4,000 robotic surgeries with SSi Mantra robotic system - The Robot Report
SS Innovations International Becomes Oversold (SSII) - Nasdaq
SSII Unchanged on Developments in Robotics - Baystreet.ca
SS Innovations Hits 4,000 Surgeries Milestone - TipRanks
SS Innovations Surpasses Milestone of 4,000 Robotic - GlobeNewswire
Surgical Robot Achieves Perfect Safety Record Across 4,000 Operations Including Remote Heart Surgeries - Stock Titan
SS Innovations appoints new CEO for Asia Pacific By Investing.com - Investing.com Nigeria
SS Innovations appoints new CEO for Asia Pacific - Investing.com Australia
SS Innovations revenue jumps 40.8% to USD 5.1M in Q1 2025 - Medical Buyer
SS Innovations Reports Record Q1 Revenue Growth - TipRanks
SS Innovations International, Inc. Reports Record Quarterly Revenue of $5.1 Million, Driven by Increased SSi Mantra 3 Sales and Plans for FDA De Novo Application - Nasdaq
Earnings Flash (SSII) SS Innovations International Posts Q1 Revenue $5.1M - marketscreener.com
SS Innovations Reports First Quarter 2025 Financial Results - The Manila Times
Vicarious Surgical, UMass partner; SS Innovations targets de novo submission - MedTech Dive
SS Innovations to submit de novo classification request for surgical robotic system - Yahoo Finance
SS Innovations to seek FDA approval for robotic system By Investing.com - Investing.com Nigeria
PB Healthcare raises $218 million to launch hospital network - eHealth Magazine
SS Innovations reiterates guidance for Q1 2025 - MSN
SS Innovations to Submit De Novo Application to the FDA for - GlobeNewswire
SS Innovations Plans FDA Submission for Robotic System - TipRanks
SS Innovations to seek FDA approval for robotic system - Investing.com
SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic ... - Bluefield Daily Telegraph
SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications - Stock Titan
SS Innovations Reports Surge in April 2025 Orders - TipRanks
SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends - The Manila Times
SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second ... - Bluefield Daily Telegraph
SS Innovations Reiterates Guidance for First Quarter 2025 - GlobeNewswire
Surgical Robot Orders Surge 200%: SS Innovations Reveals Strong Q1 Performance and Record-Breaking April Sales - Stock Titan
SSIISS Innovations Latest Stock News & Market Updates - Stock Titan
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting - The Globe and Mail
Finanzdaten der Ss Innovations International Inc-Aktie (SSII)
Es liegen keine Finanzdaten für Ss Innovations International Inc (SSII) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.52%
0.92%
Kapitalisierung:
|
Volumen (24h):